FINWIRES · TerminalLIVE
FINWIRES

EMEA Oil Update: Crude Climbs as Traders Assess Project Freedom

作者

-- Crude oil futures rose on Monday as traders showed skepticism that the US Project Freedom initiative can restore normal trade through the Strait of Hormuz.

Front-month Murban crude futures rose 1.7% to $105.49 per barrel, while Brent futures were up by 2.2% to $110.59/bbl.

"The market is steadier at the start of the new trading week, despite continued noise around developments in the Persian Gulf," ING said.

Sentiment was briefly shaken by the announcement of 'Project Freedom', a US plan to guide commercial ships out of the Strait of Hormuz.

However, initial sell-offs were quickly reversed as the market looked unconvinced by the plan's scope.

Analysts note that without active US Navy escorts for inbound vessels, the move likely only provides temporary relief by clearing out existing floating storage rather than restoring normal trade flows.

Supply concerns are further exacerbated by a lack of progress in diplomatic channels and shifts within OPEC+.

Although the group announced a 188,000 b/d supply increase for June, its first meeting since the UAE's surprise exit, market experts doubt the full volume will reach the market.

Over half of the scheduled increase is tied to Persian Gulf producers currently restricted by the Strait of Hormuz blockade.

With President Trump reportedly labeling Iran's latest peace proposal "unacceptable" and Tehran refusing to discuss nuclear terms until port blockades are lifted, crude prices continue to hold a significant risk premium.

相关文章

Mining & Metals

多伦多证券交易所指数目前上涨20点,周一早盘一度下跌120点;此前该指数在过去7个完整交易日中有6个交易日下跌。

$^GSPTSE$.GSPTSE
Australia

Gyre Therapeutics 以 3 亿美元全股票方式完成对 Cullgen 的收购

Gyre Therapeutics(股票代码:GYRE)周一宣布,已完成对临床阶段生物制药公司Cullgen的收购,此次收购以全股票交易方式进行,价值约3亿美元。 该公司表示,此次交易将收购的公司转变为其全资子公司,专注于纤维化和炎症性疾病的治疗。 Gyre Therapeutics还表示,Cullgen前首席执行官罗颖(Ying Luo)被任命为合并后公司的总裁、首席执行官兼董事会成员,而张平(Ping Zhang)将继续担任董事会主席。Price: $7.97, Change: $+0.17, Percent Change: +2.18%

$GYRE
Australia

更新:Wedbush 将 AMD 的目标股价从 290 美元上调至 400 美元,维持“跑赢大盘”评级。

(更新内容包括 Wedbush 的评论) Wedbush 将 AMD(Advanced Micro Devices)的目标股价从 290 美元上调至 400 美元,该公司即将发布第一季度财报。Wedbush 指出,AMD 的 CPU 强劲表现使其有望超出预期,并给出更高的业绩指引。 分析师 Matt Bryson 和 Antoine Legault 在周一的一份报告中写道,即使 GPU/AI 收入增长速度低于预期,对服务器计算的持续需求也将为 AMD 的未来发展提供一定的保障。 根据 FactSet 调查的分析师数据,AMD 的平均评级为“增持”,平均目标股价为 312.72 美元。 (报道北美、亚洲和欧洲主要银行及研究机构的股票、商品和经济研究。研究机构可通过以下链接联系我们:https://www..com/contact-us)Price: $345.87, Change: $-14.67, Percent Change: -4.07%

$AMD